S&P Futures
4,016.75 -15.75 (-0.39%) Dow Futures
33,651.00 -134.00 (-0.40%) Nasdaq Futures
11,902.50 -65.50 (-0.55%) Russell 2000 Futures
1,888.30 -5.20 (-0.27%) Crude Oil
77.05 -0.85 (-1.09%) Gold
1,919.20 -20.00 (-1.03%)
Vilmorin & Compagnie S.A. (4HL.SG)
Chart Events
Performance Outlook
| Previous Close | 45.60 |
| Open | 45.30 |
| Bid | 45.40 x 15000 |
| Ask | 45.55 x 15000 |
| Day's Range | 45.30 - 45.50 |
| 52 Week Range | 38.65 - 51.50 |
| Volume | |
| Avg. Volume | 4 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Combined Annual General Meeting 2022
COMBINED ANNUAL GENERAL MEETING 2022 Approval of the financial statements for 2021-2022, showing total net income of 95.4 million eurosA net dividend of 1.60 euros per share, constant in nominal value compared to the previous fiscal yearConfirmation of the objectives for 2022-2023 The Combined Annual General Meeting of Vilmorin & Cie's Shareholders was held on Friday December 9, 2022 in Cournon-d’Auvergne (France), under the chairmanship of Sébastien VIDAL, Chairman and CEO. The Shareholders the
- GlobeNewswire
Sales on September 30, 2022
Activity: driven by Field Seeds, sales for activities intended for professional markets rose sharply Objectives for 2022-2023: Vilmorin & Cie confirms its objectives for the fiscal year News: Filing of the Universal Registration Document for 2021-2022Preparation of the Combined Annual General Meeting (Ordinary and Extraordinary) of December 9, 2022 Vilmorin & Cie’s consolidated sales for the first quarter of 2022-2023, closing on September 30, 2022, corresponding to revenue from ordinary activit
- GlobeNewswire
Results for the fiscal year on June 30, 2022
Vilmorin & Cie once again demonstrates the resilience of its model by achieving solid commercial and financial performances Proposal of a dividend of 1.60 euros per share at the upcoming Annual General Meeting of Shareholders, in Auvergne News: a new research partnership concerning pulses in Canada Objectives for 2022-2023: business growth of between 6% and 8%* and a current operating margin rate of at least 8% *On a like-for-like basis. Financial statements for fiscal year 2021-2022:Vilmorin &
